Table I.
Parameter | Study group (n = 280) |
---|---|
Age, mean ± SD [years] | 44.3 ±10.6 |
Male, n (%) | 192 (68.6) |
BMI, mean ± SD [kg/m2] | 28.7 ±4.2 |
HR, mean ± SD [bpm] | 71.7 ±10.7 |
OSBP, mean ± SD [mm Hg] | 143.8 ±14.3 |
ODBP, mean ± SD [mm Hg] | 92.4 ±9.5 |
AH grade 1, n (%) | 196 (70.0) |
AH grade 2, n (%) | 67 (23.9) |
AH grade 3, n (%) | 17 (6.1) |
MS, n (%) | 153 (54.5) |
Creatinine, mean ± SD [mg/dl] | 0.84 ±0.16 |
eGFR, mean ± SD [ml/min/1.73 m2] | 100.1 ±20.8 |
ABP monitoring, mean ± SD [mm Hg]: | |
24-hour BP | 140.8/88.1 ±11.5/8.1 |
Daytime BP | 144.7/91.0 ±11.9/8.6 |
Night-time BP | 128.2/77.8 ±12.9/9.0 |
BMI – body mass index, HR – heart rate, OSBP – office systolic blood pressure, ODBP – office diastolic blood pressure, AH – arterial hypertension, MS – metabolic syndrome, eGFR – estimated glomerular filtration rate, ABP – ambulatory blood pressure, BP – blood pressure.